Aura Biosciences, Inc.

NASDAQ (USD): Aura Biosciences, Inc. (AURA)

Last Price

8.22

Today's Change

+0.04 (0.48%)

Day's Change

8.039 - 8.33

Trading Volume

58,796

Overview

Market Cap

410 Million

Shares Outstanding

49 Million

Avg Volume

207,401

Avg Price (50 Days)

9.67

Avg Price (200 Days)

8.40

PE Ratio

-4.75

EPS

-1.73

Earnings Announcement

12-Mar-2025

Previous Close

8.18

Open

8.13

Day's Range

8.045 - 8.33

Year Range

6.63 - 12.378

Trading Volume

58,844

Price Change Highlight

1 Day Change

0.31%

5 Day Change

-2.44%

1 Month Change

-8.32%

3 Month Change

-9.84%

6 Month Change

15.40%

Ytd Change

-9.14%

1 Year Change

-8.73%

3 Year Change

-53.41%

5 Year Change

-44.56%

10 Year Change

-44.56%

Max Change

-44.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment